Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Glucose Dependent Insulinotropic Receptor Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Glucose Dependent Insulinotropic Receptor Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 DA-1241
      • 1.3.3 GSK-2041706
      • 1.3.4 HD-0471042
      • 1.3.5 HD-0471953
      • 1.3.6 HOB-047
      • 1.3.7 MBX-2982
      • 1.3.8 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Glucose Dependent Insulinotropic Receptor Market Share by Application (2019-2025)
      • 1.4.2 Type 2 Diabetes
      • 1.4.3 Obesity
      • 1.4.4 Chronic Obstructive Pulmonary Disease (COPD)
      • 1.4.5 Dyslipidemia
      • 1.4.6 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Glucose Dependent Insulinotropic Receptor Market Size
      • 2.1.1 Global Glucose Dependent Insulinotropic Receptor Revenue 2014-2025
      • 2.1.2 Global Glucose Dependent Insulinotropic Receptor Sales 2014-2025
    • 2.2 Glucose Dependent Insulinotropic Receptor Growth Rate by Regions
      • 2.2.1 Global Glucose Dependent Insulinotropic Receptor Sales by Regions 2014-2019
      • 2.2.2 Global Glucose Dependent Insulinotropic Receptor Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Glucose Dependent Insulinotropic Receptor Sales by Manufacturers
      • 3.1.1 Glucose Dependent Insulinotropic Receptor Sales by Manufacturers 2014-2019
      • 3.1.2 Glucose Dependent Insulinotropic Receptor Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Glucose Dependent Insulinotropic Receptor Revenue by Manufacturers (2014-2019)
      • 3.2.2 Glucose Dependent Insulinotropic Receptor Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Glucose Dependent Insulinotropic Receptor Market Concentration Ratio (CR5 and HHI)
    • 3.3 Glucose Dependent Insulinotropic Receptor Price by Manufacturers
    • 3.4 Key Manufacturers Glucose Dependent Insulinotropic Receptor Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Glucose Dependent Insulinotropic Receptor Market
    • 3.6 Key Manufacturers Glucose Dependent Insulinotropic Receptor Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 DA-1241 Sales and Revenue (2014-2019)
      • 4.1.2 GSK-2041706 Sales and Revenue (2014-2019)
      • 4.1.3 HD-0471042 Sales and Revenue (2014-2019)
      • 4.1.4 HD-0471953 Sales and Revenue (2014-2019)
      • 4.1.5 HOB-047 Sales and Revenue (2014-2019)
      • 4.1.6 MBX-2982 Sales and Revenue (2014-2019)
      • 4.1.7 Others Sales and Revenue (2014-2019)
    • 4.2 Global Glucose Dependent Insulinotropic Receptor Sales Market Share by Type
    • 4.3 Global Glucose Dependent Insulinotropic Receptor Revenue Market Share by Type
    • 4.4 Glucose Dependent Insulinotropic Receptor Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Glucose Dependent Insulinotropic Receptor Sales by Application

    6 United States

    • 6.1 United States Glucose Dependent Insulinotropic Receptor Breakdown Data by Company
    • 6.2 United States Glucose Dependent Insulinotropic Receptor Breakdown Data by Type
    • 6.3 United States Glucose Dependent Insulinotropic Receptor Breakdown Data by Application

    7 European Union

    • 7.1 European Union Glucose Dependent Insulinotropic Receptor Breakdown Data by Company
    • 7.2 European Union Glucose Dependent Insulinotropic Receptor Breakdown Data by Type
    • 7.3 European Union Glucose Dependent Insulinotropic Receptor Breakdown Data by Application

    8 China

    • 8.1 China Glucose Dependent Insulinotropic Receptor Breakdown Data by Company
    • 8.2 China Glucose Dependent Insulinotropic Receptor Breakdown Data by Type
    • 8.3 China Glucose Dependent Insulinotropic Receptor Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Glucose Dependent Insulinotropic Receptor Breakdown Data by Company
    • 9.2 Rest of World Glucose Dependent Insulinotropic Receptor Breakdown Data by Type
    • 9.3 Rest of World Glucose Dependent Insulinotropic Receptor Breakdown Data by Application
    • 9.4 Rest of World Glucose Dependent Insulinotropic Receptor Breakdown Data by Countries
      • 9.4.1 Rest of World Glucose Dependent Insulinotropic Receptor Sales by Countries
      • 9.4.2 Rest of World Glucose Dependent Insulinotropic Receptor Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Amgen Inc
      • 10.1.1 Amgen Inc Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Glucose Dependent Insulinotropic Receptor
      • 10.1.4 Glucose Dependent Insulinotropic Receptor Product Introduction
      • 10.1.5 Amgen Inc Recent Development
    • 10.2 Arena Pharmaceuticals Inc
      • 10.2.1 Arena Pharmaceuticals Inc Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Glucose Dependent Insulinotropic Receptor
      • 10.2.4 Glucose Dependent Insulinotropic Receptor Product Introduction
      • 10.2.5 Arena Pharmaceuticals Inc Recent Development
    • 10.3 CymaBay Therapeutics Inc
      • 10.3.1 CymaBay Therapeutics Inc Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Glucose Dependent Insulinotropic Receptor
      • 10.3.4 Glucose Dependent Insulinotropic Receptor Product Introduction
      • 10.3.5 CymaBay Therapeutics Inc Recent Development
    • 10.4 Dong-A Socio Holdings Co Ltd
      • 10.4.1 Dong-A Socio Holdings Co Ltd Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Glucose Dependent Insulinotropic Receptor
      • 10.4.4 Glucose Dependent Insulinotropic Receptor Product Introduction
      • 10.4.5 Dong-A Socio Holdings Co Ltd Recent Development
    • 10.5 F. Hoffmann-La Roche Ltd
      • 10.5.1 F. Hoffmann-La Roche Ltd Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Glucose Dependent Insulinotropic Receptor
      • 10.5.4 Glucose Dependent Insulinotropic Receptor Product Introduction
      • 10.5.5 F. Hoffmann-La Roche Ltd Recent Development
    • 10.6 GlaxoSmithKline Plc
      • 10.6.1 GlaxoSmithKline Plc Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Glucose Dependent Insulinotropic Receptor
      • 10.6.4 Glucose Dependent Insulinotropic Receptor Product Introduction
      • 10.6.5 GlaxoSmithKline Plc Recent Development
    • 10.7 Hyundai Pharmaceutical Co Ltd
      • 10.7.1 Hyundai Pharmaceutical Co Ltd Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Glucose Dependent Insulinotropic Receptor
      • 10.7.4 Glucose Dependent Insulinotropic Receptor Product Introduction
      • 10.7.5 Hyundai Pharmaceutical Co Ltd Recent Development
    • 10.8 Kowa Co Ltd
      • 10.8.1 Kowa Co Ltd Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Glucose Dependent Insulinotropic Receptor
      • 10.8.4 Glucose Dependent Insulinotropic Receptor Product Introduction
      • 10.8.5 Kowa Co Ltd Recent Development
    • 10.9 Merck & Co Inc
      • 10.9.1 Merck & Co Inc Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Glucose Dependent Insulinotropic Receptor
      • 10.9.4 Glucose Dependent Insulinotropic Receptor Product Introduction
      • 10.9.5 Merck & Co Inc Recent Development
    • 10.10 Novartis AG
      • 10.10.1 Novartis AG Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Glucose Dependent Insulinotropic Receptor
      • 10.10.4 Glucose Dependent Insulinotropic Receptor Product Introduction
      • 10.10.5 Novartis AG Recent Development
    • 10.11 Taisho Pharmaceutical Holdings Co Ltd
    • 10.12 Takeda Pharmaceutical Co Ltd
    • 10.13 Yuhan Corp

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Glucose Dependent Insulinotropic Receptor Sales Channels
      • 11.2.2 Glucose Dependent Insulinotropic Receptor Distributors
    • 11.3 Glucose Dependent Insulinotropic Receptor Customers

    12 Market Forecast

    • 12.1 Global Glucose Dependent Insulinotropic Receptor Sales and Revenue Forecast 2019-2025
    • 12.2 Global Glucose Dependent Insulinotropic Receptor Sales Forecast by Type
    • 12.3 Global Glucose Dependent Insulinotropic Receptor Sales Forecast by Application
    • 12.4 Glucose Dependent Insulinotropic Receptor Forecast by Regions
      • 12.4.1 Global Glucose Dependent Insulinotropic Receptor Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Glucose Dependent Insulinotropic Receptor Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In 2019, the market size of Glucose Dependent Insulinotropic Receptor is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Glucose Dependent Insulinotropic Receptor.

      This report studies the global market size of Glucose Dependent Insulinotropic Receptor, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Glucose Dependent Insulinotropic Receptor sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Amgen Inc
      Arena Pharmaceuticals Inc
      CymaBay Therapeutics Inc
      Dong-A Socio Holdings Co Ltd
      F. Hoffmann-La Roche Ltd
      GlaxoSmithKline Plc
      Hyundai Pharmaceutical Co Ltd
      Kowa Co Ltd
      Merck & Co Inc
      Novartis AG
      Taisho Pharmaceutical Holdings Co Ltd
      Takeda Pharmaceutical Co Ltd
      Yuhan Corp

      Market Segment by Product Type
      DA-1241
      GSK-2041706
      HD-0471042
      HD-0471953
      HOB-047
      MBX-2982
      Others

      Market Segment by Application
      Type 2 Diabetes
      Obesity
      Chronic Obstructive Pulmonary Disease (COPD)
      Dyslipidemia
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Glucose Dependent Insulinotropic Receptor status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Glucose Dependent Insulinotropic Receptor manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Glucose Dependent Insulinotropic Receptor are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now